로그인
토토사이트
신규사이트
업체홍보/구인
먹튀사이트/제보
지식/노하우
놀이터홍보
판매의뢰
스포츠분석
뉴스
후기내역공유
커뮤니티
포토
포인트
보증업체
카지노
토토
홀덤
구인
구직
총판
제작업체홍보
카지노 먹튀
토토 먹튀
먹튀제보
카지노 노하우
토토 노하우
홀덤 노하우
기타 지식/노하우
유용한 사이트
토토 홍보
카지노 홍보
홀덤 홍보
꽁머니홍보
신규가입머니
제작판매
제작의뢰
게임
축구
야구
농구
배구
하키
미식축구
스포츠뉴스
연예뉴스
IT뉴스
카지노 후기
토토 후기
홀덤 후기
자유게시판
유머★이슈
동영상
연예인
섹시bj
안구정화
출석하기
포인트 랭킹
포인트 마켓
로그인
자동로그인
회원가입
정보찾기
뉴스
더보기
[IT뉴스]
[사이테크+] "나노티라누스는 어린 T.렉스 아닌 별개 종…40년 논쟁 끝"
N
[연예뉴스]
‘100만 유튜버’ 수탉, 납치→무차별 폭행당해…얼굴 피해 심각
N
[스포츠뉴스]
63빌딩보다 더 높은 곳에 위치한 ‘하늘의 축구장’
N
[연예뉴스]
정려원 "외로운데 좋다…짝 찾기 우선순위 아냐"
N
[스포츠뉴스]
[오늘의 경기] 2025년 10월 31일
N
커뮤니티
더보기
[유머★이슈]
바란 은퇴보다 더 소름돋는점
[유머★이슈]
오늘 국군의날 예행연습에 최초 공개된 장비들
[유머★이슈]
손흥민이 한국 병역 시스템에 영향 끼친 것.
[유머★이슈]
시댁의 속터지는 스무고개식 대화법
[유머★이슈]
엄마. 나 여자 임신시켜버렸어
목록
글쓰기
[IT뉴스]Rokit Healthcare and SK Chemicals Lead KOSPI’s Record High Session[K-bio Pulse]
온카뱅크관리자
조회:
13
2025-10-30 06:47:27
<div class="article_view" data-translation-body="true" data-tiara-layer="article_body" data-tiara-action-name="본문이미지확대_클릭"> <section dmcf-sid="ZsjK9WLxs1"> <div contents-hash="694ef4ada27285ecf1c12a0828f1c0f70db2a2df8308df78d266192214d8a165" dmcf-pid="5D6XZk2us5" dmcf-ptype="general"> <div> This article was released as <strong>Pharm Edaily Premium Content</strong> on October 23, 2025, at 6:44 AM. </div> </div> <p contents-hash="cf0bd3c49ea33f82c215b35326faa67366cbd5fa32dd4fdd49200c14f6323da7" dmcf-pid="1wPZ5EV7mZ" dmcf-ptype="general">[Seungkwon Kim, Edaily Reporter] Rokit Healthcare’s share price more than doubled over the past month, while SK Chemicals also saw a sharp rise amid renewed optimism across the Korean biotechnology sector. The KOSPI surged another 1.5% on Tuesday to a record 3,883 points, and bio stocks followed the upward trend.</p> <p contents-hash="98ef24a489105f4a14f4edffe1a107898c562e2fee8d6e6e609664d53a3930ea" dmcf-pid="trQ51DfzsX" dmcf-ptype="general">According to KG Zeroin, Rokit Healthcare closed at 38,650 won, up 16% from the previous day. The stock has been on a remarkable climb since early September, jumping from around 14,000 won to the upper 30,000-won range. The rally comes after the company announced that it had received public insurance reimbursement in the U.S. for its diabetic foot regeneration treatment.</p> <figure class="figure_frm origin_fig" contents-hash="93d4b5bdb4ee760b55d32b51cc1e694f4351b8b3ddba0f49d1cdc478a6aac62d" dmcf-pid="Fmx1tw4qsH" dmcf-ptype="figure"> <p class="link_figure"><img alt="Rokit Healthcare price (data=KG Zeroin)" class="thumb_g_article" data-org-src="https://t1.daumcdn.net/news/202510/30/Edaily/20251030064649784dtzt.jpg" data-org-width="456" dmcf-mid="H3pedUmjEF" dmcf-mtype="image" height="auto" src="https://img1.daumcdn.net/thumb/R658x0.q70/?fname=https://t1.daumcdn.net/news/202510/30/Edaily/20251030064649784dtzt.jpg" width="658"></p> <figcaption class="txt_caption default_figure"> Rokit Healthcare price (data=KG Zeroin) </figcaption> </figure> <div contents-hash="d7bebfd8d45f6d14a9d0530dbf08933826be697df4a4b1c971a4b7a56fd20584" dmcf-pid="3sMtFr8BOG" dmcf-ptype="general"> Rokit Healthcare said a major tertiary hospital in the U.S. has accepted public insurance coverage for its AI-based regenerative therapy for diabetic foot ulcers. This marks the first case in which AI-driven autologous tissue regeneration has been officially recognized as a medical procedure under the U.S. public insurance CPT system, which the company considers a significant milestone. </div> <p contents-hash="e4191fccded7469f8ee0cca74e91b866ca1e4abacf1b231a09680037cf56d585" dmcf-pid="0ORF3m6bwY" dmcf-ptype="general">The firm noted that official recognition in the U.S. implies both safety and efficacy validation. This development has sparked expectations that commercialization of Rokit Healthcare’s AI organ-regeneration platform will expand not only across the U.S. but also in Europe and the Middle East. The company combines AI, medical 3D bioprinting, and single-use medical kits to develop regenerative treatments for diabetic patients’ feet. Its technology uses autologous tissue-derived extracellular matrix (ECM) printed into patch form for wound coverage, achieving an average 82% regeneration success rate. Treatment costs are estimated at one-fourth of traditional diabetic foot surgery or wound care methods.</p> <p contents-hash="c533d1cf181179c503a2893937b97970d0b84a67f8f65ec2de980e5e009a77ad" dmcf-pid="pIe30sPKEW" dmcf-ptype="general">CEO You Seok-hwan stated, “This is the first case of an AI-based regenerative medical procedure being incorporated into the U.S. official insurance system. We expect global insurance approvals to accelerate rapidly. Rokit Healthcare aims to usher in the era of personalized regenerative medicine, moving beyond mass treatment approaches.”</p> <figure class="figure_frm origin_fig" contents-hash="5e3b99895633226cc953e516f8e10eb0e2eb9a93316a051cd9a009217e52acee" dmcf-pid="UCd0pOQ9wy" dmcf-ptype="figure"> <p class="link_figure"><img alt="T&R Bio (data=KG Zeroin)" class="thumb_g_article" data-org-src="https://t1.daumcdn.net/news/202510/30/Edaily/20251030064651145dnbh.jpg" data-org-width="440" dmcf-mid="X9YgaKSrIt" dmcf-mtype="image" height="auto" src="https://img3.daumcdn.net/thumb/R658x0.q70/?fname=https://t1.daumcdn.net/news/202510/30/Edaily/20251030064651145dnbh.jpg" width="658"></p> <figcaption class="txt_caption default_figure"> T&R Bio (data=KG Zeroin) </figcaption> </figure> <div contents-hash="d3c377700326fc97f148e2fe9907e474b1d1e4f11bff9ed525445763d2f58190" dmcf-pid="usMtFr8BOT" dmcf-ptype="general"> SK Chemicals also soared following news that it signed a memorandum of understanding (MOU) with AriBio for expanded development and global commercialization of AR1001 (mirodenafil), an oral Alzheimer’s therapy. AR1001 is based on mirodenafil, originally developed by SK Chemicals and licensed to AriBio in 2011. AriBio is currently conducting Phase 3 global clinical trials across 13 countries to verify the drug’s efficacy and safety. </div> <p contents-hash="7ccc8a9d8ee70284d28ccffe22235c4f29d7e2b48c771fcd555a950c44c3bea8" dmcf-pid="7ORF3m6bmv" dmcf-ptype="general">Under the new MOU, the two companies will collaborate on next-generation formulations of mirodenafil, joint global trials, and AR1001’s commercial manufacturing and export. The agreement reflects their shared confidence in the ongoing Phase 3 program and the drug’s commercialization potential. AriBio’s POLARIS-AD Phase 3 study has enrolled 1,535 patients across the U.S., Europe, Korea, and China. The company plans to complete the trial in the first half of 2026, disclose top-line results, and submit a New Drug Application (NDA) to the U.S. FDA by the end of the same year.</p> <p contents-hash="aefcbb49ba2c7f9c3ada0a2db8fe355cd2d28defd5c8b1e0567e65c538ca1cb1" dmcf-pid="zIe30sPKDS" dmcf-ptype="general">Meanwhile, T&R Biofab closed at 2,280 won, up 13% from the previous session. The company’s rising stock price has been supported by investor confidence in its capital increase and new product outlook. T&R Biofab announced that its rights offering achieved an oversubscription rate of 102.15%, with strong participation from existing shareholders. The offering totaled 15.9 million new shares, with total subscriptions reaching 16.2 million shares. Foreign investors have also been net buyers for five consecutive trading days, accumulating approximately 437,400 shares.</p> <p contents-hash="2d13f0e5f9b30bd72fc0be3a081f3febcd11f09e4004c2370e5921e53909ee53" dmcf-pid="qCd0pOQ9wl" dmcf-ptype="general">김승권 (peace@edaily.co.kr) </p> </section> </div> <p class="" data-translation="true">Copyright © 이데일리. 무단전재 및 재배포 금지.</p>
댓글등록
댓글 총
0
개
맨위로
이번주
포인트
랭킹
매주 일요일 밤 0시에 랭킹을 초기화합니다.
1
4,000
상품권
2
3,000
상품권
3
2,000
상품권
업체홍보/구인
더보기
[구인]
유투브 BJ 구인중이자나!완전 럭키비키자나!
[구인]
에카벳에서 최대 조건으로 부본사 및 회원님들 모집합니다
[구인]
카지노 1번 총판 코드 내립니다.
[구인]
어느날 부본사 총판 파트너 모집합니다.
[구인]
고액전용 카지노 / 헬렌카지노 파트너 개인 팀 단위 모집중 최고우대
놀이터홍보
더보기
[홀덤 홍보]
텍사스홀덤 핸드 순위- 홀카드의 가치
[홀덤 홍보]
텍사스홀덤 핸드 순위 - 프리플랍(Pre-Flop) 핸드 랭킹
[토토 홍보]
미니게임개발제작 전문업체 포유소프트를 추천드립니다.
[토토 홍보]
2023년 일본 만화 판매량 순위 공개
[토토 홍보]
무료만화 사이트 보는곳 3가지 추천
지식/노하우
더보기
[카지노 노하우]
혜택 트렌드 변화 위험성 다시 가늠해 보기
[카지노 노하우]
호기심이 부른 화 종목 선택의 중요성
[카지노 노하우]
카지노 블랙잭 카드 조합으로 히트와 스탠드를 결정하는 방법
[카지노 노하우]
흥부가 놀부될때까지 7
[카지노 노하우]
5월 마틴하면서 느낀점
판매의뢰
더보기
[제작판매]
html5웹미니게임제작 해시게임제작 카드포커게임제작 스포츠토토 카지노 슬롯 에볼루션 토지노 솔루션분양임대재작
[제작판매]
html5웹미니게임제작 해시게임제작 카드포커게임제작 스포츠토토 카지노 슬롯 에볼루션 토지노 솔루션분양임대재작
[제작판매]
html5웹미니게임제작 해시게임제작 카드포커게임제작 스포츠토토 카지노 슬롯 에볼루션 토지노 솔루션분양임대재작
[제작판매]
html5웹미니게임제작 해시게임제작 카드포커게임제작 스포츠토토 카지노 슬롯 에볼루션 토지노 솔루션분양임대재작
[제작판매]
html5웹미니게임제작 해시게임제작 카드포커게임제작 스포츠토토 카지노 슬롯 에볼루션 토지노 솔루션분양임대재작
포토
더보기
채팅하기